相关实验视频
Updated: Jul 12, 2025
08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.0K
CEP55作为一个有希望的免疫干预标记器来调节瘤进展:全癌症分析与实验验证
Gang Wang1,2,3, Bo Chen1,2,3, Yue Su1,2,3
1Department of Pharmacology, College of Pharmacy, Chongqing Medical University, Chongqing 400016, China.
Cells
|October 27, 2023
概括
在大多数癌症中,中间体蛋白55 (CEP55) 的含量升高,影响患者的预后并促进瘤的进展. 向CEP55可能为癌症治疗和免疫透调节提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 中心蛋白55 (CEP55) 参与细胞分裂和癌症进展.
- CEP55在泛癌免疫透中的预后价值和作用在很大程度上仍未被描述.
研究的目的:
- 研究各种癌症中CEP55表达的情况.
- 分析CEP55与临床病理特征,预后和免疫透之间的相关性.
- 为了确定潜在的CEP55向抑制剂.
主要方法:
- 使用多个数据库分析用于癌CEP55表达.
- 与临床数据,患者预后和免疫细胞透相关的CEP55水平.
- 对乳腺癌细胞进行了体外实验,以评估CEP55的功能.
- 对CEP55向小分子抑制剂进行选.
主要成果:
- 与正常组织相比,CEP55表达在大多数瘤组织中显著上调.
- CEP55水平与病理等级,患者年龄和整体预后相关.
- CEP55 Knockdown 抑制了乳腺癌细胞的增殖和迁移;过度表达促进了这些过程.
- CEP55表达与免疫细胞透,免疫检查点和与免疫相关的基因具有积极的相关性.
- CD-437被确定为一种潜在的CEP55抑制剂.
结论:
- CEP55 作为多种癌症类型的显著预后生物标志物.
- CEP55影响癌症的进展,并调节瘤的免疫微环境.
- CEP55代表了癌症干预的潜在治疗目标,特别是在免疫透方面.
更多相关视频
09:32Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
14.7K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
795
相关概念视频
01:27Tumor Immunotherapy
538
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
538
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K